Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production - PubMed (original) (raw)
Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production
J J Cook et al. J Clin Invest. 1988 Jan.
Abstract
We examined human growth hormone's (hGH) effect on mitogenesis in cultured human fibroblasts, and the role of local insulin-like growth factor I (IGF-I). With 0.5% human hypopituitary serum (HPS), hGH increased thymidine incorporation (TI) over serum-free medium dose responsively, with half-maximal effect at 10 ng/ml (0.5 nM) (hGH 127 +/- 8.8%; IGF-I 107 +/- 1.7% [SEM]) (n = 10). Similarly, with 0.5% HPS, hGH and IGF-I increased cell replication by 172 +/- 8.2% and 169 +/- 25%, respectively (n = 4). Specific IGF-I monoclonal antibody (Sm1.2) dose dependently blunted TI stimulated by 10 ng/ml hGH or IGF-I (at 1:1000, 38 +/- 6.5% and 30 +/- 14% reduction, respectively). Sm1.2 also reduced cell replication by both 10 ng/ml hGH and IGF-I, respectively, to 32% and 42% of stimulated values. Dexamethasone (0.1 microM) synergistically enhanced TI by both IGF-I and hGH. A 28-h time course for TI showed that hGH stimulated a similar peak to IGF-I, lagging in its effect by 4-10 h. We have provided further evidence that hGH stimulates growth of cultured human fibroblasts via local IGF-I production, consistent with IGF-I's paracrine-autocrine role.
Similar articles
- Direct evidence that the insulin receptor mediates a mitogenic response in cultured human fibroblasts.
Conover A, Hintz RL, Rosenfeld RG. Conover A, et al. Horm Metab Res. 1989 Feb;21(2):59-63. doi: 10.1055/s-2007-1009151. Horm Metab Res. 1989. PMID: 2722129 - Insulin-like growth factor I/somatomedin-C (IGF-I/SM-C) and glucocorticoids synergistically regulate mitosis in competent human fibroblasts.
Conover CA, Dollar LA, Hintz RL, Rosenfeld RG. Conover CA, et al. J Cell Physiol. 1983 Aug;116(2):191-7. doi: 10.1002/jcp.1041160210. J Cell Physiol. 1983. PMID: 6306016 - Hormonal control of the replication of human fetal fibroblasts: role of somatomedin C/insulin-like growth factor I.
Conover CA, Rosenfeld RG, Hintz RL. Conover CA, et al. J Cell Physiol. 1986 Jul;128(1):47-54. doi: 10.1002/jcp.1041280109. J Cell Physiol. 1986. PMID: 3013906 - Differential effects of glucocorticoids on insulin-like growth factor I action in cultured human fibroblasts.
Conover CA, Hintz RL, Johnson BF. Conover CA, et al. J Cell Physiol. 1995 Jun;163(3):615-22. doi: 10.1002/jcp.1041630323. J Cell Physiol. 1995. PMID: 7775603
Cited by
- Efficacy of cooling therapy and α-lipoic acid derivative against chemotherapy-induced alopecia in an animal model.
Aiba T, Kono Y, Etoh T, Kawano Y, Oshima Y, Inomata M. Aiba T, et al. Cancer Sci. 2023 Mar;114(3):1007-1014. doi: 10.1111/cas.15639. Epub 2022 Nov 15. Cancer Sci. 2023. PMID: 36337052 Free PMC article. - Evaluation of the Effect of Topical Melatonin Application on Immediately Placed Dental Implants Using Cone Beam Computed Tomography (CBCT).
Ravi Kiran S, Bammidi N, Kumar AK, Kumar PS, Karnam Y. Ravi Kiran S, et al. Cureus. 2022 May 23;14(5):e25233. doi: 10.7759/cureus.25233. eCollection 2022 May. Cureus. 2022. PMID: 35755538 Free PMC article. - Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia.
Yoneda K, Fujii M, Imaoka A, Kobayashi R, Hayashi R, Yoshida Y, Kohno T, Tsuji T. Yoneda K, et al. Support Care Cancer. 2021 Oct;29(10):6127-6134. doi: 10.1007/s00520-021-06189-7. Epub 2021 Apr 2. Support Care Cancer. 2021. PMID: 33797584 - Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis.
Alotaibi NM, Noormohamed N, Cote DJ, Alharthi S, Doucette J, Zaidi HA, Mekary RA, Smith TR. Alotaibi NM, et al. World Neurosurg. 2018 Jan;109:487-496.e1. doi: 10.1016/j.wneu.2017.09.164. Epub 2017 Oct 4. World Neurosurg. 2018. PMID: 28987837 Free PMC article. Review. - Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways.
Cui T, Jimenez JJ, Block NL, Badiavas EV, Rodriguez-Menocal L, Vila Granda A, Cai R, Sha W, Zarandi M, Perez R, Schally AV. Cui T, et al. Oncotarget. 2016 Aug 16;7(33):52661-52672. doi: 10.18632/oncotarget.11024. Oncotarget. 2016. PMID: 27494841 Free PMC article.
References
- Science. 1982 Jun 11;216(4551):1237-9 - PubMed
- Proc Natl Acad Sci U S A. 1979 Mar;76(3):1279-83 - PubMed
- Endocrinology. 1986 May;118(5):1843-8 - PubMed
- C R Seances Acad Sci III. 1982 Nov 29;295(11):651-4 - PubMed
- Endocrinology. 1980 Jun;106(6):2006-12 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources